Have a personal or library account? Click to login
Effectiveness and safety of dexamphetamine sulfate (Attentin®) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study Cover

Effectiveness and safety of dexamphetamine sulfate (Attentin®) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study

Scandinavian Journal of Child and Adolescent Psychiatry and Psychology
Volume 9 (2021): Issue 1 (January 2021)
By: Henrik Uebel-von Sandersleben,  Oliver Dangel,  Roland Fischer,  Michaela Ruhmann and  Michael Huss  
Open Access
|Apr 2021

Authors

Henrik Uebel-von Sandersleben

huebel@gwdg.de

University Medical Center Göttingen, Department of Child and Adolescent Psychiatry and Psychotherapy, Göttingen, Germany

Oliver Dangel

MEDICE Arzneimittel Pütter GmbH & Co KG, Iserlohn, Germany

Roland Fischer

MEDICE Arzneimittel Pütter GmbH & Co KG, Iserlohn, Germany

Michaela Ruhmann

MEDICE Arzneimittel Pütter GmbH & Co KG, Iserlohn, Germany

Michael Huss

Johannes Gutenberg-University, Mainz, Germany
DOI: https://doi.org/10.21307/sjcapp-2021-009 | Journal eISSN: 2245-8875
Journal RSS Feed
Language: English
Page range: 73 - 86
Published on: Apr 23, 2021
Published by: Psychiatric Research Unit
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
ADHD,
dexamphetamine,
children,
adolescents
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2021 Henrik Uebel-von Sandersleben, Oliver Dangel, Roland Fischer, Michaela Ruhmann, Michael Huss, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 9 (2021): Issue 1 (January 2021)Next article